218 related articles for article (PubMed ID: 18525338)
1. Targeting insulin-like growth factor 1 receptor in sarcomas.
Scotlandi K; Picci P
Curr Opin Oncol; 2008 Jul; 20(4):419-27. PubMed ID: 18525338
[TBL] [Abstract][Full Text] [Related]
2. Resistance pathways relevant to insulin-like growth factor-1 receptor-targeted therapy.
Hendrickson AW; Haluska P
Curr Opin Investig Drugs; 2009 Oct; 10(10):1032-40. PubMed ID: 19777391
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
Friedrichs N; Küchler J; Endl E; Koch A; Czerwitzki J; Wurst P; Metzger D; Schulte JH; Holst MI; Heukamp LC; Larsson O; Tanaka S; Kawai A; Wardelmann E; Buettner R; Pietsch T; Hartmann W
J Pathol; 2008 Dec; 216(4):428-39. PubMed ID: 18855347
[TBL] [Abstract][Full Text] [Related]
4. Novel agents in development for pediatric sarcomas.
Hughes DP
Curr Opin Oncol; 2009 Jul; 21(4):332-7. PubMed ID: 19444103
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway--therapeutic perspectives in cancer.
Tao Y; Pinzi V; Bourhis J; Deutsch E
Nat Clin Pract Oncol; 2007 Oct; 4(10):591-602. PubMed ID: 17898809
[TBL] [Abstract][Full Text] [Related]
6. Targeting IGF-1R in the treatment of sarcomas: past, present and future.
Kim SY; Wan X; Helman LJ
Bull Cancer; 2009; 96(7):E52-60. PubMed ID: 19617179
[TBL] [Abstract][Full Text] [Related]
7. The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer.
Ryan PD; Goss PE
Oncologist; 2008 Jan; 13(1):16-24. PubMed ID: 18245009
[TBL] [Abstract][Full Text] [Related]
8. The insulin-like growth factor system and sarcomas.
Rikhof B; de Jong S; Suurmeijer AJ; Meijer C; van der Graaf WT
J Pathol; 2009 Mar; 217(4):469-82. PubMed ID: 19148905
[TBL] [Abstract][Full Text] [Related]
9. Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer.
Hofmann F; García-Echeverría C
Drug Discov Today; 2005 Aug; 10(15):1041-7. PubMed ID: 16055020
[TBL] [Abstract][Full Text] [Related]
10. The insulin-like growth factor 1 receptor in cancer: old focus, new future.
Hartog H; Wesseling J; Boezen HM; van der Graaf WT
Eur J Cancer; 2007 Sep; 43(13):1895-904. PubMed ID: 17624760
[TBL] [Abstract][Full Text] [Related]
11. A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: in vitro and in vivo study.
Martins AS; Ordoñez JL; García-Sánchez A; Herrero D; Sevillano V; Osuna D; Mackintosh C; Caballero G; Otero AP; Poremba C; Madoz-Gúrpide J; de Alava E
Cancer Res; 2008 Aug; 68(15):6260-70. PubMed ID: 18676850
[TBL] [Abstract][Full Text] [Related]
12. New targets for therapy of sarcoma.
Magenau JM; Schuetze SM
Curr Opin Oncol; 2008 Jul; 20(4):400-6. PubMed ID: 18525335
[TBL] [Abstract][Full Text] [Related]
13. IGF1R signalling and its inhibition.
Riedemann J; Macaulay VM
Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S33-43. PubMed ID: 17259557
[TBL] [Abstract][Full Text] [Related]
14. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
Cunningham MP; Thomas H; Marks C; Green M; Fan Z; Modjtahedi H
Int J Oncol; 2008 Nov; 33(5):1107-13. PubMed ID: 18949375
[TBL] [Abstract][Full Text] [Related]
15. Radiation and new molecular agents, part II: targeting HDAC, HSP90, IGF-1R, PI3K, and Ras.
Chinnaiyan P; Allen GW; Harari PM
Semin Radiat Oncol; 2006 Jan; 16(1):59-64. PubMed ID: 16378908
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the insulin-like growth factor 1 receptor pathway enhances the antitumor effect of cisplatin in human malignant mesothelioma cell lines.
Kai K; D'Costa S; Sills RC; Kim Y
Cancer Lett; 2009 Jun; 278(1):49-55. PubMed ID: 19178995
[TBL] [Abstract][Full Text] [Related]
17. The insulin-like growth factor signaling pathway as a target for treatment of colorectal carcinoma.
Ewing GP; Goff LW
Clin Colorectal Cancer; 2010 Oct; 9(4):219-23. PubMed ID: 20920993
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I and breast cancer therapy.
Ibrahim YH; Yee D
Clin Cancer Res; 2005 Jan; 11(2 Pt 2):944s-50s. PubMed ID: 15701891
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y
Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy in adult soft tissue sarcoma.
Jain A; Sajeevan KV; Babu KG; Lakshmaiah KC
Indian J Cancer; 2009; 46(4):274-87. PubMed ID: 19749457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]